首页> 外文学位 >Phytochemical study of Psoralea glandulosa, Cestrum parqui and Indigofera heterantha; rearrangement mechanism in oxidation of thiophene aminotriazinone; synthesis of amino acid and peptide analogues of chicoric acid as HIV-1 integrase inhibitors.
【24h】

Phytochemical study of Psoralea glandulosa, Cestrum parqui and Indigofera heterantha; rearrangement mechanism in oxidation of thiophene aminotriazinone; synthesis of amino acid and peptide analogues of chicoric acid as HIV-1 integrase inhibitors.

机译:补骨脂,小C和靛蓝的植物化学研究;噻吩氨基三嗪酮的氧化重排机理合成壳聚糖的氨基酸和肽类似物作为HIV-1整合酶抑制剂。

获取原文
获取原文并翻译 | 示例

摘要

Natural products have played and continue to play an invaluable role in the drug discovery process related to all disease types. One advantage of medicinal plants is that some screening has already been done by a long history of usage by traditional healers of indigenous cultures. Therefore, there is a much better chance to find drug leads.;Three plants, Psoralea glandulosa, Cestrum parqui and Indigofera heterantha were studied for anti-feedant activity, dopaminergic activity and antitumor activity, respectively. Bioassay guided isolation gave ten compounds including bakuchiol analogs, an isoflavone, furanocoumarins from Psoralea glandulosa, chlorogenic acid from Cestrum parqui and berberine and 8-oxyberberine from Indigofera heterantha.;The acquired immunodeficiency syndrome (AIDS) pandemic has promoted an intensive effort to identify and synthesize new drugs to target its causative agent, the human immunodeficiency virus (HIV). Preliminary studies in this laboratory examined 60 Kallawayan plants for anti-HIV activity which ultimately led to a new class of HIV type 1 integrase inhibitors. The lead compound in this series, L-dicaffeoyltartaric acid or L-chicoric acid. Structure-activity relationship studies (SAR) found that at least one carboxylic acid and two catechols are necessary. Different linkages between the two catechols and the carboxylic groups can change the anti-HIV IN activities. Analogs with two amide linkages, one amide and one ester linkage, two amine linkages, peptide linkages and heterocyclic linkages have been synthesized. Replacement of the ester by an amide linkage retains but modifies the anti-HIV IN activity. The amine linkage resulted in the loss of activity. Analogs with peptide and heterocyclic linkages have only moderate activity. Modification of the catechols to galloyl groups gave active Nalpha, Nbeta-bis-galloyl-2,3-diaminopropionic acid, highly toxic digalloyltartaric acid and inactive Nalpha, N&egr;-bisgalloyllysine.;Oxidation of thiophene aminotriazinone in methanol gave 99.3% 5a and 0.7% rearrangement product 5. The rearrangement mechanism was investigated with a 13C labeled precursor. Two possible mechanisms were suggested (Scheme 1). Either the 13C will be scrambled if the intermediate is the cumulated ketene 22 but remain at C-2 if the cyclopropanone mechanism is operative. The latter result was found.*;*Please refer to dissertation for diagrams.
机译:天然产物在与所有疾病类型相关的药物发现过程中一直发挥着并将继续发挥着不可估量的作用。药用植物的一个优点是,传统的本土文化治疗者使用悠久的历史已经进行了一些筛选。因此,有更好的机会找到药物先导。研究了三种植物,分别为补骨脂,多叶草和异花靛蓝的抗饲料活性,多巴胺能活性和抗肿瘤活性。生物测定指导下的分离得到了十种化合物,包括补骨脂酚类似物,异黄酮,来自Psoralea glandulosa的呋喃香豆素,来自Cestrum parqui和小genic的绿原酸和来自Indigofera heterantha的8-氧小ber碱;获得性免疫缺陷综合症(AIDS)大流行促进了识别和鉴定大流行的努力。合成新药以针对其病原体,即人类免疫缺陷病毒(HIV)。在该实验室中的初步研究检查了60种Kallawayan植物的抗HIV活性,最终导致了新型的HIV 1型整合酶抑制剂。该系列中的主要化合物,L-二咖啡酰酒石酸或L-衣康酸。结构活性关系研究(SAR)发现,至少需要一种羧酸和两种邻苯二酚。两个邻苯二酚和羧基之间的不同连接可以改变抗HIV IN的活性。已合成具有两个酰胺键,一个酰胺键和一个酯键,两个胺键,肽键和杂环键的类似物。用酰胺键取代酯可保留但修饰抗HIV IN活性。胺键导致活性降低。具有肽和杂环键的类似物仅具有中等活性。将儿茶酚修饰成没食子酰基,得到活性的Nalpha,Nbeta-双-galloyl-2,3-二氨基丙酸,剧毒的二没食子儿基酒石酸和无活性的nalpha,N&egr;-双没食子酰基赖氨酸。在甲醇中噻吩氨基三嗪酮的氧化得到99.3%5a和0.7 %重排产物5。用13C标记的前体研究了重排机理。建议了两种可能的机制(方案1)。如果中间体是累积的乙烯酮22,则13C都将加扰,但如果环丙烷机理起作用,则13C将保持在C-2。找到后一个结果。*; *请参考论文的图表。

著录项

  • 作者

    Li, Chengwei.;

  • 作者单位

    Texas Christian University.;

  • 授予单位 Texas Christian University.;
  • 学科 Chemistry Organic.;Chemistry Pharmaceutical.
  • 学位 Ph.D.
  • 年度 2004
  • 页码 276 p.
  • 总页数 276
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号